Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07296900

International Genetic Obesity Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
University of Ulm · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Genetic obesity results from changes in specific genes that affect appetite regulation, metabolism, and fat storage. Its severity and associated health issues vary depending on the genetic cause. In some cases, hormonal imbalances, developmental delays, or other complications may also occur. Identifying the genetic cause is essential for personalized treatment and understanding potential symptoms. As genetic obesity is rare, specialists often encounter few patients with diverse genetic backgrounds and clinical features. Therefore, collecting global data is crucial to improve our understanding of the condition's progression, complications, and treatment responses for each genetic subtype. To support this, the International Genetic Obesity Registry (iGO Registry) has been established to gather detailed patient information on genetic obesity. This registry will help advance research and improve clinical care for affected individuals. It will collect data from routine outpatient visits, focusing on relevant diagnostic and treatment information on an international level.

Conditions

Timeline

Start date
2025-11-17
Primary completion
2075-11-01
Completion
2075-11-01
First posted
2025-12-22
Last updated
2025-12-22

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT07296900. Inclusion in this directory is not an endorsement.